Published in Malar J on December 02, 2008
Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine | NCT01867463
Preventing the Spread of Malaria in Mali | NCT01360112
Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, Mali | NCT03304704
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One (2012) 1.57
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity. PLoS One (2011) 1.05
Platform for Plasmodium vivax vaccine discovery and development. Mem Inst Oswaldo Cruz (2011) 0.81
Infectiousness of the human population to Anopheles arabiensis by direct skin feeding in an area hypoendemic for malaria in Senegal. Am J Trop Med Hyg (2015) 0.81
Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission. PLoS Negl Trop Dis (2016) 0.80
Membrane feeding of dengue patient's blood as a substitute for direct skin feeding in studying Aedes-dengue virus interaction. Parasit Vectors (2016) 0.76
Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study. Vaccine (2016) 0.75
Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region. Science (2006) 4.38
Factors determining the true reservoir of infection of Plasmodium falciparum and Wuchereria bancrofti in a West African village. Trans R Soc Trop Med Hyg (1954) 4.33
Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J (2004) 2.84
Malaria parasite development in mosquitoes. Annu Rev Entomol (1998) 2.83
Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1974) 2.22
The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans R Soc Trop Med Hyg (1992) 2.20
Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology (1989) 2.10
Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology (1988) 1.89
Human malaria infectiousness measured by age-specific sporozoite rates in Anopheles gambiae in Tanzania. Parasitology (1991) 1.87
The malarial infectivity of an African village population to mosquitoes (Anopheles gambiae); a random xenodiagnostic survey. Am J Trop Med Hyg (1957) 1.71
Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies. Am J Trop Med Hyg (1990) 1.62
Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science (1991) 1.59
Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ (1979) 1.43
Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol (1988) 1.38
Transmission-blocking vaccines: uses and current status of development. Int J Parasitol (1997) 1.33
Immunity to sexual stages of malaria parasites. Prog Allergy (1988) 1.31
The early sporogonic cycle of Plasmodium falciparum in laboratory-infected Anopheles gambiae: an estimation of parasite efficacy. Trop Med Int Health (1998) 1.25
Malaria transmission-blocking activity in experimental infections of Anopheles gambiae from naturally infected Plasmodium falciparum gametocyte carriers. Trans R Soc Trop Med Hyg (1994) 1.07
Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon. Parasite Immunol (1996) 1.04
Age-structured gametocyte allocation links immunity to epidemiology in malaria parasites. Malar J (2007) 0.99
Mechanisms that reduce transmission of Plasmodium falciparum malaria in semiimmune and nonimmune persons. J Infect Dis (1998) 0.94
Plasmodium falciparum transmission blocking immunity under conditions of low and high endemicity in Cameroon. Parasite Immunol (2004) 0.91
The pathogenic basis of malaria. Nature (2002) 10.44
Malaria transmission in urban sub-Saharan Africa. Am J Trop Med Hyg (2003) 6.28
Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg (2003) 5.43
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region. Science (2006) 4.38
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
A field trial to assess a blood-stage malaria vaccine. N Engl J Med (2011) 3.20
X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med (2007) 2.94
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A (2010) 2.90
Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J (2004) 2.84
Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis (2008) 2.77
Season, fever prevalence and pyrogenic threshold for malaria disease definition in an endemic area of Mali. Trop Med Int Health (2005) 2.57
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol (2011) 2.54
Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J (2008) 2.49
Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali. Acta Trop (2003) 2.47
Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol (2009) 2.43
False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg (2012) 2.43
Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg (2003) 2.29
Ethical data release in genome-wide association studies in developing countries. PLoS Med (2009) 2.23
A geographic sampling strategy for studying relationships between human activity and malaria vectors in urban Africa. Am J Trop Med Hyg (2003) 2.22
Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol Biochem Parasitol (2006) 2.22
A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med (2009) 2.21
Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village. BMC Public Health (2006) 2.20
Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A (2008) 2.19
Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature (2005) 2.17
Valid consent for genomic epidemiology in developing countries. PLoS Med (2007) 2.14
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. Vaccine (2009) 2.12
Genetic loci affecting resistance to human malaria parasites in a West African mosquito vector population. Science (2002) 2.11
Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A (2007) 2.07
Malaria prevalence and associated risk factors in Eritrea. Am J Trop Med Hyg (2005) 2.06
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog (2010) 2.03
Successful field trial of attractive toxic sugar bait (ATSB) plant-spraying methods against malaria vectors in the Anopheles gambiae complex in Mali, West Africa. Malar J (2010) 2.01
Community permission for medical research in developing countries. Clin Infect Dis (2005) 2.01
MalariaSphere: a greenhouse-enclosed simulation of a natural Anopheles gambiae (Diptera: Culicidae) ecosystem in western Kenya. Malar J (2002) 2.01
Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. Am J Trop Med Hyg (2008) 1.95
Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med (2009) 1.95
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial. PLoS One (2008) 1.90
Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg (2002) 1.88
Larval habitat diversity and ecology of anopheline larvae in Eritrea. J Med Entomol (2003) 1.88
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg (2012) 1.87
Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis (2005) 1.86
Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg (2005) 1.86
Examining the determinants of mosquito-avoidance practices in two Kenyan cities. Malar J (2002) 1.84
Estimating dispersal and survival of Anopheles gambiae and Anopheles funestus along the Kenyan coast by using mark-release-recapture methods. J Med Entomol (2007) 1.83
Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med (2007) 1.78
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. Clin Infect Dis (2011) 1.74
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. Am J Trop Med Hyg (2008) 1.72
An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis (2013) 1.72
Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens. J Infect Dis (2011) 1.71
Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. Vaccine (2004) 1.70
Blood-meal analysis for anopheline mosquitoes sampled along the Kenyan coast. J Am Mosq Control Assoc (2003) 1.69
Source reduction of mosquito larval habitats has unexpected consequences on malaria transmission. Proc Natl Acad Sci U S A (2006) 1.67
Shifts in malaria vector species composition and transmission dynamics along the Kenyan coast over the past 20 years. Malar J (2013) 1.65
Malaria and the red cell. Hematology Am Soc Hematol Educ Program (2002) 1.64
Malaria transmission in relation to rice cultivation in the irrigated Sahel of Mali. Acta Trop (2004) 1.63
A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis (2007) 1.61
Characterization of potential larval habitats for Anopheles mosquitoes in relation to urban land-use in Malindi, Kenya. Int J Health Geogr (2004) 1.61
Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg (2003) 1.58
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One (2012) 1.57
The etiology of severe anemia in a village and a periurban area in Mali. Blood (2004) 1.55
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity. Am J Trop Med Hyg (2007) 1.55
Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children. PLoS One (2008) 1.54
Malaria in selected non-Amazonian countries of Latin America. Acta Trop (2011) 1.53
Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial. PLoS Clin Trials (2006) 1.47
Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa. Epilepsia (2006) 1.45
A test of the chromosomal theory of ecotypic speciation in Anopheles gambiae. Proc Natl Acad Sci U S A (2008) 1.45
Influence of sugar availability and indoor microclimate on survival of Anopheles gambiae (Diptera: Culicidae) under semifield conditions in western Kenya. J Med Entomol (2003) 1.44
Bed bugs in healthcare settings. Infect Control Hosp Epidemiol (2012) 1.43
At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells. J Immunol (2010) 1.42
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. Am J Trop Med Hyg (2006) 1.41
A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa. Malar J (2006) 1.41
In vitro growth-inhibitory activity and malaria risk in a cohort study in mali. Infect Immun (2009) 1.39
An effective method to purify Plasmodium falciparum DNA directly from clinical blood samples for whole genome high-throughput sequencing. PLoS One (2011) 1.39
An individual-based model of Plasmodium falciparum malaria transmission on the coast of Kenya. Trans R Soc Trop Med Hyg (2003) 1.37
Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali. Microbes Infect (2004) 1.36
Low recovery rates stabilize malaria endemicity in areas of low transmission in coastal Kenya. Acta Trop (2003) 1.36
SEASONALITY, PARASITE DIVERSITY, AND LOCAL EXTINCTIONS IN PLASMODIUM FALCIPARUM MALARIA. Ecology (2001) 1.36
Characterization of within-host Plasmodium falciparum diversity using next-generation sequence data. PLoS One (2012) 1.36
Effect of discriminative plant-sugar feeding on the survival and fecundity of Anopheles gambiae. Malar J (2007) 1.35
Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites. PLoS Pathog (2012) 1.35
Linking field-based ecological data with remotely sensed data using a geographic information system in two malaria endemic urban areas of Kenya. Malar J (2003) 1.35
Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. Am J Trop Med Hyg (2006) 1.33
A biologic basis for integrated malaria control. Am J Trop Med Hyg (2002) 1.30
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. J Infect Dis (2013) 1.30
Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. J Infect Dis (2012) 1.30
Distribution of anopheline mosquitoes in Eritrea. Am J Trop Med Hyg (2003) 1.28
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar J (2010) 1.27
First detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from cutaneous leishmaniasis foci in Mali. PLoS One (2012) 1.26
High seasonal variation in entomologic inoculation rates in Eritrea, a semi-arid region of unstable malaria in Africa. Am J Trop Med Hyg (2003) 1.26
Natural plant sugar sources of Anopheles mosquitoes strongly impact malaria transmission potential. PLoS One (2011) 1.26
The distribution of hatching time in Anopheles gambiae. Malar J (2006) 1.25